Publication:
Radiation Treatment for WHO Grade II and III Meningiomas

Thumbnail Image

Open/View Files

Date

2013

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

Frontiers Media S.A.
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Walcott, Brian P., Brian V. Nahed, Priscilla K. Brastianos, and Jay S. Loeffler. 2013. “Radiation Treatment for WHO Grade II and III Meningiomas.” Frontiers in Oncology 3 (1): 227. doi:10.3389/fonc.2013.00227. http://dx.doi.org/10.3389/fonc.2013.00227.

Research Data

Abstract

The treatment of meningiomas is tailored to their histological grade. While World Health Organization (WHO) grade I lesions can be treated with either surgery or external beam radiation, WHO Grade II and III lesions often require a combination of the two modalities. For these high-grade lesions, conventional external beam radiation is delivered to either the residual tumor or the surgical resection margin. The optimal timing of radiation, either immediately following surgical resection or at the time of recurrence, is yet to be determined. Additionally, another method of radiation delivery, brachytherapy, can be administered locally at the time of surgery for recurrent lesions. Altogether, the complex nature of WHO grade II and III meningiomas requires careful treatment planning and delivery by a multidisciplinary team.

Description

Keywords

Review Article, meningioma, radiosurgery, proton therapy, surgery, brachytherapy

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories